International audience
-
August 14, 2020 (v1)Journal articleUploaded on: December 4, 2022
-
September 1, 2016 (v1)Journal articleVascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
International audience
Uploaded on: December 4, 2022 -
October 22, 2021 (v1)Journal article
A network dependency platform was generated to define a landscape of cancer drug mechanisms in pulmonary hypertension.
Uploaded on: December 4, 2022 -
October 22, 2021 (v1)Journal article
A network dependency platform was generated to define a landscape of cancer drug mechanisms in pulmonary hypertension.
Uploaded on: February 22, 2023 -
October 22, 2021 (v1)Journal article
Cancer therapies are being considered for treating rare noncancerous diseases like pulmonary hypertension (PH), but effective computational screening is lacking. Via transcriptomic differential dependency analyses leveraging parallels between cancer and PH, we mapped a landscape of cancer drug functions dependent upon rewiring of PH gene...
Uploaded on: December 3, 2022 -
May 7, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
January 10, 2024 (v1)Journal article
Hypoxic reprogramming of vasculature relies on genetic, epigenetic, and metabolic circuitry, but the control points are unknown. In pulmonary arterial hypertension (PAH), a disease driven by hypoxia inducible factor (HIF)–dependent vascular dysfunction, HIF-2α promoted expression of neighboring genes, long noncoding RNA (lncRNA) histone lysine...
Uploaded on: October 16, 2024